bionexuslab 0.1.0__tar.gz
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- bionexuslab-0.1.0/.github/workflows/ci.yml +47 -0
- bionexuslab-0.1.0/.github/workflows/release.yml +41 -0
- bionexuslab-0.1.0/.gitignore +11 -0
- bionexuslab-0.1.0/LICENSE +202 -0
- bionexuslab-0.1.0/PKG-INFO +202 -0
- bionexuslab-0.1.0/README.md +180 -0
- bionexuslab-0.1.0/bionexus.db +0 -0
- bionexuslab-0.1.0/campaign_report.html +419 -0
- bionexuslab-0.1.0/contracts/README.md +30 -0
- bionexuslab-0.1.0/contracts/v1/assay_result.yaml +71 -0
- bionexuslab-0.1.0/contracts/v1/envelope.yaml +47 -0
- bionexuslab-0.1.0/contracts/v1/protocol_submission.yaml +89 -0
- bionexuslab-0.1.0/contracts/v1/provenance_record.yaml +89 -0
- bionexuslab-0.1.0/contracts/v1/stage_task.yaml +96 -0
- bionexuslab-0.1.0/contracts/v1/tool_invocation.yaml +92 -0
- bionexuslab-0.1.0/diagrams/README.md +27 -0
- bionexuslab-0.1.0/diagrams/artifacts/01-layered-view.html +287 -0
- bionexuslab-0.1.0/diagrams/artifacts/02-iteration-loop.html +151 -0
- bionexuslab-0.1.0/diagrams/artifacts/03-tournament.html +138 -0
- bionexuslab-0.1.0/diagrams/artifacts/04-wetlab-roundtrip.html +145 -0
- bionexuslab-0.1.0/diagrams/artifacts/05-branching.html +138 -0
- bionexuslab-0.1.0/diagrams/artifacts/06-campaign.html +140 -0
- bionexuslab-0.1.0/diagrams/artifacts/index.html +51 -0
- bionexuslab-0.1.0/diagrams/svg/01-layered-view.svg +123 -0
- bionexuslab-0.1.0/diagrams/svg/02-iteration-loop.svg +89 -0
- bionexuslab-0.1.0/diagrams/svg/03-tournament.svg +75 -0
- bionexuslab-0.1.0/diagrams/svg/04-wetlab-roundtrip.svg +82 -0
- bionexuslab-0.1.0/diagrams/svg/05-branching.svg +76 -0
- bionexuslab-0.1.0/diagrams/svg/06-campaign.svg +79 -0
- bionexuslab-0.1.0/docs/ADAPTERS.md +91 -0
- bionexuslab-0.1.0/docs/PLAN.md +102 -0
- bionexuslab-0.1.0/docs/QUICKSTART.md +56 -0
- bionexuslab-0.1.0/docs/SAFETY.md +56 -0
- bionexuslab-0.1.0/docs/architecture.md +107 -0
- bionexuslab-0.1.0/docs/benchmarks.md +89 -0
- bionexuslab-0.1.0/docs/blocks/A-orchestration.md +45 -0
- bionexuslab-0.1.0/docs/blocks/B-agents.md +56 -0
- bionexuslab-0.1.0/docs/blocks/C-models-knowledge.md +49 -0
- bionexuslab-0.1.0/docs/blocks/D-lab-execution.md +56 -0
- bionexuslab-0.1.0/docs/blocks/E-simulation-data.md +29 -0
- bionexuslab-0.1.0/docs/blocks/F-infrastructure.md +34 -0
- bionexuslab-0.1.0/docs/domain-review.md +46 -0
- bionexuslab-0.1.0/docs/flows.md +154 -0
- bionexuslab-0.1.0/docs/research-landscape.md +89 -0
- bionexuslab-0.1.0/docs/security.md +65 -0
- bionexuslab-0.1.0/docs/stability.md +57 -0
- bionexuslab-0.1.0/docs/virtual-lab.md +41 -0
- bionexuslab-0.1.0/examples/demo_imaging.py +57 -0
- bionexuslab-0.1.0/examples/full_campaign.py +326 -0
- bionexuslab-0.1.0/examples/iteration_loop.py +104 -0
- bionexuslab-0.1.0/examples/run_benchmark.py +51 -0
- bionexuslab-0.1.0/examples/run_benchmark_hardened.py +53 -0
- bionexuslab-0.1.0/examples/run_benchmark_real.py +128 -0
- bionexuslab-0.1.0/examples/run_llm_ablation.py +57 -0
- bionexuslab-0.1.0/examples/workflow.yml +24 -0
- bionexuslab-0.1.0/notebooks/01_run_a_campaign.ipynb +100 -0
- bionexuslab-0.1.0/notebooks/02_write_an_adapter.ipynb +99 -0
- bionexuslab-0.1.0/notebooks/03_bring_your_own_model.ipynb +89 -0
- bionexuslab-0.1.0/notebooks/04_imaging_and_benchmarks.ipynb +93 -0
- bionexuslab-0.1.0/pyproject.toml +42 -0
- bionexuslab-0.1.0/src/bionexus/__init__.py +15 -0
- bionexuslab-0.1.0/src/bionexus/adapters/__init__.py +0 -0
- bionexuslab-0.1.0/src/bionexus/adapters/bio/__init__.py +0 -0
- bionexuslab-0.1.0/src/bionexus/adapters/bio/rdkit_ops.py +52 -0
- bionexuslab-0.1.0/src/bionexus/adapters/data/__init__.py +0 -0
- bionexuslab-0.1.0/src/bionexus/adapters/data/moleculenet.py +60 -0
- bionexuslab-0.1.0/src/bionexus/adapters/lab/__init__.py +0 -0
- bionexuslab-0.1.0/src/bionexus/adapters/lab/devices.py +170 -0
- bionexuslab-0.1.0/src/bionexus/adapters/lab/imaging.py +224 -0
- bionexuslab-0.1.0/src/bionexus/adapters/lab/recording.py +119 -0
- bionexuslab-0.1.0/src/bionexus/adapters/lab/simulator.py +165 -0
- bionexuslab-0.1.0/src/bionexus/adapters/models/__init__.py +0 -0
- bionexuslab-0.1.0/src/bionexus/adapters/models/anthropic_provider.py +74 -0
- bionexuslab-0.1.0/src/bionexus/adapters/models/gnn_policy.py +138 -0
- bionexuslab-0.1.0/src/bionexus/adapters/models/llm_policy.py +187 -0
- bionexuslab-0.1.0/src/bionexus/adapters/models/openai_compat.py +86 -0
- bionexuslab-0.1.0/src/bionexus/adapters/models/sklearn_policy.py +46 -0
- bionexuslab-0.1.0/src/bionexus/adapters/sandbox/__init__.py +0 -0
- bionexuslab-0.1.0/src/bionexus/adapters/sandbox/agentenv.py +136 -0
- bionexuslab-0.1.0/src/bionexus/adapters/sandbox/local.py +84 -0
- bionexuslab-0.1.0/src/bionexus/adapters/store/__init__.py +0 -0
- bionexuslab-0.1.0/src/bionexus/adapters/store/sqlite.py +80 -0
- bionexuslab-0.1.0/src/bionexus/benchmark.py +282 -0
- bionexuslab-0.1.0/src/bionexus/cli.py +197 -0
- bionexuslab-0.1.0/src/bionexus/core/__init__.py +0 -0
- bionexuslab-0.1.0/src/bionexus/core/contracts/__init__.py +35 -0
- bionexuslab-0.1.0/src/bionexus/core/contracts/models.py +341 -0
- bionexuslab-0.1.0/src/bionexus/core/flywheel.py +70 -0
- bionexuslab-0.1.0/src/bionexus/core/hypothesis.py +194 -0
- bionexuslab-0.1.0/src/bionexus/core/interfaces.py +153 -0
- bionexuslab-0.1.0/src/bionexus/core/registry.py +98 -0
- bionexuslab-0.1.0/src/bionexus/core/safety.py +129 -0
- bionexuslab-0.1.0/src/bionexus/core/workflow.py +159 -0
- bionexuslab-0.1.0/src/bionexus/mcp_server.py +210 -0
- bionexuslab-0.1.0/src/bionexus/report.py +107 -0
- bionexuslab-0.1.0/src/bionexus/scaffold.py +192 -0
- bionexuslab-0.1.0/tests/__init__.py +0 -0
- bionexuslab-0.1.0/tests/test_adapters_ext.py +418 -0
- bionexuslab-0.1.0/tests/test_core.py +171 -0
|
@@ -0,0 +1,47 @@
|
|
|
1
|
+
name: ci
|
|
2
|
+
|
|
3
|
+
on:
|
|
4
|
+
push:
|
|
5
|
+
branches: [main]
|
|
6
|
+
pull_request:
|
|
7
|
+
|
|
8
|
+
jobs:
|
|
9
|
+
core: # P1: fast, dependency-light, no network
|
|
10
|
+
runs-on: ubuntu-latest
|
|
11
|
+
steps:
|
|
12
|
+
- uses: actions/checkout@v4
|
|
13
|
+
- uses: actions/setup-python@v5
|
|
14
|
+
with: { python-version: "3.12" }
|
|
15
|
+
- run: pip install pydantic pytest && pip install -e . --no-deps
|
|
16
|
+
- run: python -m pytest tests/ -q # includes the anti-bloat import scan
|
|
17
|
+
|
|
18
|
+
example: # P8: full round on the simulator
|
|
19
|
+
runs-on: ubuntu-latest
|
|
20
|
+
steps:
|
|
21
|
+
- uses: actions/checkout@v4
|
|
22
|
+
- uses: actions/setup-python@v5
|
|
23
|
+
with: { python-version: "3.12" }
|
|
24
|
+
- run: pip install pydantic pytest pyyaml && pip install -e . --no-deps
|
|
25
|
+
- run: python examples/iteration_loop.py
|
|
26
|
+
- run: python -m bionexus.cli prove branch-root --db bionexus.db
|
|
27
|
+
|
|
28
|
+
full-campaign: # P8: entire pipeline flow on the virtual lab, then playback
|
|
29
|
+
runs-on: ubuntu-latest
|
|
30
|
+
steps:
|
|
31
|
+
- uses: actions/checkout@v4
|
|
32
|
+
- uses: actions/setup-python@v5
|
|
33
|
+
with: { python-version: "3.12" }
|
|
34
|
+
- run: pip install pydantic pytest && pip install -e . --no-deps
|
|
35
|
+
- run: python examples/full_campaign.py
|
|
36
|
+
- run: python -m bionexus.cli prove campaign-root --db campaign.db
|
|
37
|
+
- run: python -m pytest tests/ -q # now includes recording-playback test
|
|
38
|
+
|
|
39
|
+
yaml-workflow:
|
|
40
|
+
runs-on: ubuntu-latest
|
|
41
|
+
steps:
|
|
42
|
+
- uses: actions/checkout@v4
|
|
43
|
+
- uses: actions/setup-python@v5
|
|
44
|
+
with: { python-version: "3.12" }
|
|
45
|
+
- run: pip install pydantic pyyaml && pip install -e . --no-deps
|
|
46
|
+
- run: python -m bionexus.cli run examples/workflow.yml
|
|
47
|
+
- run: python -m bionexus.cli prove demo-run
|
|
@@ -0,0 +1,41 @@
|
|
|
1
|
+
name: release
|
|
2
|
+
|
|
3
|
+
# Publishes to PyPI via Trusted Publishing (no token in repo).
|
|
4
|
+
# One-time setup on pypi.org: add a pending publisher
|
|
5
|
+
# project: bionexuslab · owner: rbalachandar · repo: bionexus
|
|
6
|
+
# workflow: release.yml · environment: pypi
|
|
7
|
+
on:
|
|
8
|
+
push:
|
|
9
|
+
tags: ["v*"]
|
|
10
|
+
|
|
11
|
+
jobs:
|
|
12
|
+
build:
|
|
13
|
+
runs-on: ubuntu-latest
|
|
14
|
+
steps:
|
|
15
|
+
- uses: actions/checkout@v4
|
|
16
|
+
- uses: actions/setup-python@v5
|
|
17
|
+
with: { python-version: "3.12" }
|
|
18
|
+
- run: pip install build && python -m build
|
|
19
|
+
- uses: actions/upload-artifact@v4
|
|
20
|
+
with:
|
|
21
|
+
name: dist
|
|
22
|
+
path: dist/
|
|
23
|
+
|
|
24
|
+
publish:
|
|
25
|
+
needs: build
|
|
26
|
+
runs-on: ubuntu-latest
|
|
27
|
+
environment: pypi
|
|
28
|
+
permissions:
|
|
29
|
+
id-token: write # Trusted Publishing (OIDC)
|
|
30
|
+
steps:
|
|
31
|
+
- uses: actions/download-artifact@v4
|
|
32
|
+
with: { name: dist, path: dist/ }
|
|
33
|
+
- uses: pypa/gh-action-pypi-publish@release/v1
|
|
34
|
+
|
|
35
|
+
smoke: # install the published wheel and run one command
|
|
36
|
+
needs: publish
|
|
37
|
+
runs-on: ubuntu-latest
|
|
38
|
+
steps:
|
|
39
|
+
- uses: actions/setup-python@v5
|
|
40
|
+
with: { python-version: "3.12" }
|
|
41
|
+
- run: pip install bionexuslab==${GITHUB_REF_NAME#v} && bn new-adapter lab smoke --dir /tmp && ls /tmp/smoke_adapter
|
|
@@ -0,0 +1,202 @@
|
|
|
1
|
+
|
|
2
|
+
Apache License
|
|
3
|
+
Version 2.0, January 2004
|
|
4
|
+
http://www.apache.org/licenses/
|
|
5
|
+
|
|
6
|
+
TERMS AND CONDITIONS FOR USE, REPRODUCTION, AND DISTRIBUTION
|
|
7
|
+
|
|
8
|
+
1. Definitions.
|
|
9
|
+
|
|
10
|
+
"License" shall mean the terms and conditions for use, reproduction,
|
|
11
|
+
and distribution as defined by Sections 1 through 9 of this document.
|
|
12
|
+
|
|
13
|
+
"Licensor" shall mean the copyright owner or entity authorized by
|
|
14
|
+
the copyright owner that is granting the License.
|
|
15
|
+
|
|
16
|
+
"Legal Entity" shall mean the union of the acting entity and all
|
|
17
|
+
other entities that control, are controlled by, or are under common
|
|
18
|
+
control with that entity. For the purposes of this definition,
|
|
19
|
+
"control" means (i) the power, direct or indirect, to cause the
|
|
20
|
+
direction or management of such entity, whether by contract or
|
|
21
|
+
otherwise, or (ii) ownership of fifty percent (50%) or more of the
|
|
22
|
+
outstanding shares, or (iii) beneficial ownership of such entity.
|
|
23
|
+
|
|
24
|
+
"You" (or "Your") shall mean an individual or Legal Entity
|
|
25
|
+
exercising permissions granted by this License.
|
|
26
|
+
|
|
27
|
+
"Source" form shall mean the preferred form for making modifications,
|
|
28
|
+
including but not limited to software source code, documentation
|
|
29
|
+
source, and configuration files.
|
|
30
|
+
|
|
31
|
+
"Object" form shall mean any form resulting from mechanical
|
|
32
|
+
transformation or translation of a Source form, including but
|
|
33
|
+
not limited to compiled object code, generated documentation,
|
|
34
|
+
and conversions to other media types.
|
|
35
|
+
|
|
36
|
+
"Work" shall mean the work of authorship, whether in Source or
|
|
37
|
+
Object form, made available under the License, as indicated by a
|
|
38
|
+
copyright notice that is included in or attached to the work
|
|
39
|
+
(an example is provided in the Appendix below).
|
|
40
|
+
|
|
41
|
+
"Derivative Works" shall mean any work, whether in Source or Object
|
|
42
|
+
form, that is based on (or derived from) the Work and for which the
|
|
43
|
+
editorial revisions, annotations, elaborations, or other modifications
|
|
44
|
+
represent, as a whole, an original work of authorship. For the purposes
|
|
45
|
+
of this License, Derivative Works shall not include works that remain
|
|
46
|
+
separable from, or merely link (or bind by name) to the interfaces of,
|
|
47
|
+
the Work and Derivative Works thereof.
|
|
48
|
+
|
|
49
|
+
"Contribution" shall mean any work of authorship, including
|
|
50
|
+
the original version of the Work and any modifications or additions
|
|
51
|
+
to that Work or Derivative Works thereof, that is intentionally
|
|
52
|
+
submitted to Licensor for inclusion in the Work by the copyright owner
|
|
53
|
+
or by an individual or Legal Entity authorized to submit on behalf of
|
|
54
|
+
the copyright owner. For the purposes of this definition, "submitted"
|
|
55
|
+
means any form of electronic, verbal, or written communication sent
|
|
56
|
+
to the Licensor or its representatives, including but not limited to
|
|
57
|
+
communication on electronic mailing lists, source code control systems,
|
|
58
|
+
and issue tracking systems that are managed by, or on behalf of, the
|
|
59
|
+
Licensor for the purpose of discussing and improving the Work, but
|
|
60
|
+
excluding communication that is conspicuously marked or otherwise
|
|
61
|
+
designated in writing by the copyright owner as "Not a Contribution."
|
|
62
|
+
|
|
63
|
+
"Contributor" shall mean Licensor and any individual or Legal Entity
|
|
64
|
+
on behalf of whom a Contribution has been received by Licensor and
|
|
65
|
+
subsequently incorporated within the Work.
|
|
66
|
+
|
|
67
|
+
2. Grant of Copyright License. Subject to the terms and conditions of
|
|
68
|
+
this License, each Contributor hereby grants to You a perpetual,
|
|
69
|
+
worldwide, non-exclusive, no-charge, royalty-free, irrevocable
|
|
70
|
+
copyright license to reproduce, prepare Derivative Works of,
|
|
71
|
+
publicly display, publicly perform, sublicense, and distribute the
|
|
72
|
+
Work and such Derivative Works in Source or Object form.
|
|
73
|
+
|
|
74
|
+
3. Grant of Patent License. Subject to the terms and conditions of
|
|
75
|
+
this License, each Contributor hereby grants to You a perpetual,
|
|
76
|
+
worldwide, non-exclusive, no-charge, royalty-free, irrevocable
|
|
77
|
+
(except as stated in this section) patent license to make, have made,
|
|
78
|
+
use, offer to sell, sell, import, and otherwise transfer the Work,
|
|
79
|
+
where such license applies only to those patent claims licensable
|
|
80
|
+
by such Contributor that are necessarily infringed by their
|
|
81
|
+
Contribution(s) alone or by combination of their Contribution(s)
|
|
82
|
+
with the Work to which such Contribution(s) was submitted. If You
|
|
83
|
+
institute patent litigation against any entity (including a
|
|
84
|
+
cross-claim or counterclaim in a lawsuit) alleging that the Work
|
|
85
|
+
or a Contribution incorporated within the Work constitutes direct
|
|
86
|
+
or contributory patent infringement, then any patent licenses
|
|
87
|
+
granted to You under this License for that Work shall terminate
|
|
88
|
+
as of the date such litigation is filed.
|
|
89
|
+
|
|
90
|
+
4. Redistribution. You may reproduce and distribute copies of the
|
|
91
|
+
Work or Derivative Works thereof in any medium, with or without
|
|
92
|
+
modifications, and in Source or Object form, provided that You
|
|
93
|
+
meet the following conditions:
|
|
94
|
+
|
|
95
|
+
(a) You must give any other recipients of the Work or
|
|
96
|
+
Derivative Works a copy of this License; and
|
|
97
|
+
|
|
98
|
+
(b) You must cause any modified files to carry prominent notices
|
|
99
|
+
stating that You changed the files; and
|
|
100
|
+
|
|
101
|
+
(c) You must retain, in the Source form of any Derivative Works
|
|
102
|
+
that You distribute, all copyright, patent, trademark, and
|
|
103
|
+
attribution notices from the Source form of the Work,
|
|
104
|
+
excluding those notices that do not pertain to any part of
|
|
105
|
+
the Derivative Works; and
|
|
106
|
+
|
|
107
|
+
(d) If the Work includes a "NOTICE" text file as part of its
|
|
108
|
+
distribution, then any Derivative Works that You distribute must
|
|
109
|
+
include a readable copy of the attribution notices contained
|
|
110
|
+
within such NOTICE file, excluding those notices that do not
|
|
111
|
+
pertain to any part of the Derivative Works, in at least one
|
|
112
|
+
of the following places: within a NOTICE text file distributed
|
|
113
|
+
as part of the Derivative Works; within the Source form or
|
|
114
|
+
documentation, if provided along with the Derivative Works; or,
|
|
115
|
+
within a display generated by the Derivative Works, if and
|
|
116
|
+
wherever such third-party notices normally appear. The contents
|
|
117
|
+
of the NOTICE file are for informational purposes only and
|
|
118
|
+
do not modify the License. You may add Your own attribution
|
|
119
|
+
notices within Derivative Works that You distribute, alongside
|
|
120
|
+
or as an addendum to the NOTICE text from the Work, provided
|
|
121
|
+
that such additional attribution notices cannot be construed
|
|
122
|
+
as modifying the License.
|
|
123
|
+
|
|
124
|
+
You may add Your own copyright statement to Your modifications and
|
|
125
|
+
may provide additional or different license terms and conditions
|
|
126
|
+
for use, reproduction, or distribution of Your modifications, or
|
|
127
|
+
for any such Derivative Works as a whole, provided Your use,
|
|
128
|
+
reproduction, and distribution of the Work otherwise complies with
|
|
129
|
+
the conditions stated in this License.
|
|
130
|
+
|
|
131
|
+
5. Submission of Contributions. Unless You explicitly state otherwise,
|
|
132
|
+
any Contribution intentionally submitted for inclusion in the Work
|
|
133
|
+
by You to the Licensor shall be under the terms and conditions of
|
|
134
|
+
this License, without any additional terms or conditions.
|
|
135
|
+
Notwithstanding the above, nothing herein shall supersede or modify
|
|
136
|
+
the terms of any separate license agreement you may have executed
|
|
137
|
+
with Licensor regarding such Contributions.
|
|
138
|
+
|
|
139
|
+
6. Trademarks. This License does not grant permission to use the trade
|
|
140
|
+
names, trademarks, service marks, or product names of the Licensor,
|
|
141
|
+
except as required for reasonable and customary use in describing the
|
|
142
|
+
origin of the Work and reproducing the content of the NOTICE file.
|
|
143
|
+
|
|
144
|
+
7. Disclaimer of Warranty. Unless required by applicable law or
|
|
145
|
+
agreed to in writing, Licensor provides the Work (and each
|
|
146
|
+
Contributor provides its Contributions) on an "AS IS" BASIS,
|
|
147
|
+
WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or
|
|
148
|
+
implied, including, without limitation, any warranties or conditions
|
|
149
|
+
of TITLE, NON-INFRINGEMENT, MERCHANTABILITY, or FITNESS FOR A
|
|
150
|
+
PARTICULAR PURPOSE. You are solely responsible for determining the
|
|
151
|
+
appropriateness of using or redistributing the Work and assume any
|
|
152
|
+
risks associated with Your exercise of permissions under this License.
|
|
153
|
+
|
|
154
|
+
8. Limitation of Liability. In no event and under no legal theory,
|
|
155
|
+
whether in tort (including negligence), contract, or otherwise,
|
|
156
|
+
unless required by applicable law (such as deliberate and grossly
|
|
157
|
+
negligent acts) or agreed to in writing, shall any Contributor be
|
|
158
|
+
liable to You for damages, including any direct, indirect, special,
|
|
159
|
+
incidental, or consequential damages of any character arising as a
|
|
160
|
+
result of this License or out of the use or inability to use the
|
|
161
|
+
Work (including but not limited to damages for loss of goodwill,
|
|
162
|
+
work stoppage, computer failure or malfunction, or any and all
|
|
163
|
+
other commercial damages or losses), even if such Contributor
|
|
164
|
+
has been advised of the possibility of such damages.
|
|
165
|
+
|
|
166
|
+
9. Accepting Warranty or Additional Liability. While redistributing
|
|
167
|
+
the Work or Derivative Works thereof, You may choose to offer,
|
|
168
|
+
and charge a fee for, acceptance of support, warranty, indemnity,
|
|
169
|
+
or other liability obligations and/or rights consistent with this
|
|
170
|
+
License. However, in accepting such obligations, You may act only
|
|
171
|
+
on Your own behalf and on Your sole responsibility, not on behalf
|
|
172
|
+
of any other Contributor, and only if You agree to indemnify,
|
|
173
|
+
defend, and hold each Contributor harmless for any liability
|
|
174
|
+
incurred by, or claims asserted against, such Contributor by reason
|
|
175
|
+
of your accepting any such warranty or additional liability.
|
|
176
|
+
|
|
177
|
+
END OF TERMS AND CONDITIONS
|
|
178
|
+
|
|
179
|
+
APPENDIX: How to apply the Apache License to your work.
|
|
180
|
+
|
|
181
|
+
To apply the Apache License to your work, attach the following
|
|
182
|
+
boilerplate notice, with the fields enclosed by brackets "[]"
|
|
183
|
+
replaced with your own identifying information. (Don't include
|
|
184
|
+
the brackets!) The text should be enclosed in the appropriate
|
|
185
|
+
comment syntax for the file format. We also recommend that a
|
|
186
|
+
file or class name and description of purpose be included on the
|
|
187
|
+
same "printed page" as the copyright notice for easier
|
|
188
|
+
identification within third-party archives.
|
|
189
|
+
|
|
190
|
+
Copyright [yyyy] [name of copyright owner]
|
|
191
|
+
|
|
192
|
+
Licensed under the Apache License, Version 2.0 (the "License");
|
|
193
|
+
you may not use this file except in compliance with the License.
|
|
194
|
+
You may obtain a copy of the License at
|
|
195
|
+
|
|
196
|
+
http://www.apache.org/licenses/LICENSE-2.0
|
|
197
|
+
|
|
198
|
+
Unless required by applicable law or agreed to in writing, software
|
|
199
|
+
distributed under the License is distributed on an "AS IS" BASIS,
|
|
200
|
+
WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.
|
|
201
|
+
See the License for the specific language governing permissions and
|
|
202
|
+
limitations under the License.
|
|
@@ -0,0 +1,202 @@
|
|
|
1
|
+
Metadata-Version: 2.5
|
|
2
|
+
Name: bionexuslab
|
|
3
|
+
Version: 0.1.0
|
|
4
|
+
Summary: Lean open-source framework for agentic drug discovery — pluggable models, bio tools, labs, and sandboxes behind five core interfaces.
|
|
5
|
+
License: Apache-2.0
|
|
6
|
+
License-File: LICENSE
|
|
7
|
+
Requires-Python: >=3.10
|
|
8
|
+
Requires-Dist: pydantic>=2.5
|
|
9
|
+
Provides-Extra: bio-rdkit
|
|
10
|
+
Requires-Dist: rdkit>=2023.9; extra == 'bio-rdkit'
|
|
11
|
+
Provides-Extra: dev
|
|
12
|
+
Requires-Dist: pytest>=8; extra == 'dev'
|
|
13
|
+
Provides-Extra: lab-imaging
|
|
14
|
+
Requires-Dist: numpy>=1.24; extra == 'lab-imaging'
|
|
15
|
+
Provides-Extra: models-openai
|
|
16
|
+
Requires-Dist: httpx>=0.27; extra == 'models-openai'
|
|
17
|
+
Provides-Extra: sandbox-agentenv
|
|
18
|
+
Requires-Dist: httpx>=0.27; extra == 'sandbox-agentenv'
|
|
19
|
+
Provides-Extra: store-postgres
|
|
20
|
+
Requires-Dist: psycopg[binary]>=3; extra == 'store-postgres'
|
|
21
|
+
Description-Content-Type: text/markdown
|
|
22
|
+
|
|
23
|
+
# BioNexus
|
|
24
|
+
|
|
25
|
+
A **lean open-source framework for agentic drug discovery** — pluggable models, bio
|
|
26
|
+
tools, labs, and sandboxes behind five core interfaces.
|
|
27
|
+
|
|
28
|
+
Core dependencies: `pydantic` only. Everything else (models, labs, sandboxes,
|
|
29
|
+
stores) is an adapter you opt into.
|
|
30
|
+
|
|
31
|
+
## Quickstart (simulator-first, no network needed)
|
|
32
|
+
|
|
33
|
+
```sh
|
|
34
|
+
python -m venv .venv && .venv/bin/pip install -e . dev-dependencies... # see pyproject
|
|
35
|
+
.venv/bin/pip install -e ".[dev]"
|
|
36
|
+
.venv/bin/python examples/iteration_loop.py # full design round on the virtual lab
|
|
37
|
+
.venv/bin/python -m pytest # 11 tests, <1s, offline
|
|
38
|
+
```
|
|
39
|
+
|
|
40
|
+
The example runs: candidate generation → hypothesis tournament → human-approvable
|
|
41
|
+
protocol → **safety engine** → virtual wet lab → fork branch → safety rejection demo →
|
|
42
|
+
hash-chained provenance. See [`docs/PLAN.md`](docs/PLAN.md) for the full build plan.
|
|
43
|
+
|
|
44
|
+
### Simulated lab devices with image readouts
|
|
45
|
+
|
|
46
|
+
The virtual lab goes one level deeper: a simulated **imaging plate reader**. A
|
|
47
|
+
protocol run captures raw fluorescence micrographs per well (96-well plate), an
|
|
48
|
+
analysis pipeline fits dose–response IC50s **from the images**, and assay QC is a
|
|
49
|
+
Z' factor computed from controls. Measured IC50s recover the seeded ground truth
|
|
50
|
+
within realistic noise, and the raw well images are kept as evidence that agents
|
|
51
|
+
(or vision-capable LLMs) can inspect:
|
|
52
|
+
|
|
53
|
+
```sh
|
|
54
|
+
.venv/bin/pip install numpy # [lab-imaging] extra
|
|
55
|
+
.venv/bin/python examples/demo_imaging.py
|
|
56
|
+
# run img-c2f0183b: Z'=0.938 (controls PASS)
|
|
57
|
+
# compound measured IC50 ground truth
|
|
58
|
+
# C2 11.98 uM 10.85 uM
|
|
59
|
+
# raw evidence: 14 well images in .data/images/
|
|
60
|
+
```
|
|
61
|
+
|
|
62
|
+
Failure modes are simulated too: well artifacts (pipetting spikes, bubbles, edge
|
|
63
|
+
effects) are flagged, weak compounds are right-censored (no IC50 — test higher
|
|
64
|
+
concentrations), and runs failing Z' QC are marked unusable. See
|
|
65
|
+
[`docs/virtual-lab.md`](docs/virtual-lab.md).
|
|
66
|
+
|
|
67
|
+
**CLI:**
|
|
68
|
+
|
|
69
|
+
```sh
|
|
70
|
+
bn run examples/workflow.yml # tournament + assay on the configured lab
|
|
71
|
+
bn sim # reference round on the virtual lab
|
|
72
|
+
bn prove <branch> --html out.html # tamper-evident provenance + shareable report
|
|
73
|
+
bn mcp # MCP server: drive BioNexus from Claude/Cursor
|
|
74
|
+
```
|
|
75
|
+
|
|
76
|
+
**Works with Claude / Cursor / any MCP client** — add to your MCP config:
|
|
77
|
+
|
|
78
|
+
```json
|
|
79
|
+
{"bionexus": {"command": "bn", "args": ["mcp"]}}
|
|
80
|
+
```
|
|
81
|
+
|
|
82
|
+
Exposes `generate_candidates`, `run_assay` (dose-response + IC50),
|
|
83
|
+
`propose_hypothesis`, and `list_lab_capabilities` as agent tools.
|
|
84
|
+
|
|
85
|
+
**Tutorials:** [`notebooks/`](notebooks/) — run a campaign · write an adapter · bring your own model.
|
|
86
|
+
|
|
87
|
+
**Extend it:**
|
|
88
|
+
|
|
89
|
+
```sh
|
|
90
|
+
bn new-adapter lab my_robot # scaffold a tested LabAdapter in seconds
|
|
91
|
+
bn new-adapter tool my_docking --cap e.sim.docking
|
|
92
|
+
```
|
|
93
|
+
|
|
94
|
+
See [`docs/ADAPTERS.md`](docs/ADAPTERS.md) and the
|
|
95
|
+
[stability policy](docs/stability.md) — the five core interfaces are stable
|
|
96
|
+
surfaces with additive-evolution guarantees.
|
|
97
|
+
|
|
98
|
+
| Doc | Contents |
|
|
99
|
+
|---|---|
|
|
100
|
+
| [`docs/QUICKSTART.md`](docs/QUICKSTART.md) | install, run, workflows |
|
|
101
|
+
| [`docs/ADAPTERS.md`](docs/ADAPTERS.md) | authoring adapters (labs, models, tools, stores) |
|
|
102
|
+
| [`docs/SAFETY.md`](docs/SAFETY.md) | safety rules, LabGateway, audit trail |
|
|
103
|
+
| [`docs/domain-review.md`](docs/domain-review.md) | flow fidelity review vs. the real drug-discovery cycle |
|
|
104
|
+
| [`docs/benchmarks.md`](docs/benchmarks.md) | public datasets (MoleculeNet, TDC, DOCKSTRING, ProteinGym) + first benchmark results |
|
|
105
|
+
| [`docs/virtual-lab.md`](docs/virtual-lab.md) | simulated devices, image-based readouts, QC and failure modes |
|
|
106
|
+
| [`docs/security.md`](docs/security.md) | threat model, trust boundaries, agent capability matrix |
|
|
107
|
+
| [`docs/stability.md`](docs/stability.md) | versioning, stability tiers, deprecation policy |
|
|
108
|
+
| [`docs/PLAN.md`](docs/PLAN.md) | build plan, principles, guardrails |
|
|
109
|
+
|
|
110
|
+
### Five core interfaces (everything is one of these)
|
|
111
|
+
|
|
112
|
+
| Interface | Adapters (now → roadmap) |
|
|
113
|
+
|---|---|
|
|
114
|
+
| `ModelProvider` | openai_compat (OpenAI/ollama/vLLM/stub) → anthropic, gemini |
|
|
115
|
+
| `LabAdapter` (+ `SafetyEngine`, `LabGateway`) | simulator, imaging-simulator (synthetic plate images + analysis + Z' QC) → opentrons, cloud labs |
|
|
116
|
+
| `Sandbox` | local (copy-on-fork) → AgentENV (real fork/snapshot) |
|
|
117
|
+
| `ProvenanceStore` | sqlite → postgres, s3-worm |
|
|
118
|
+
| `BioTool` | rdkit descriptors → docking, ADMET, ESMFold |
|
|
119
|
+
|
|
120
|
+
## Architecture Diagrams
|
|
121
|
+
|
|
122
|
+
Hand-drawn blueprint-style diagrams (SVG — rendered directly on GitHub):
|
|
123
|
+
|
|
124
|
+
**1 · Layered View** — L0 governance → L3 infrastructure, with the five architectural blocks between.
|
|
125
|
+
|
|
126
|
+

|
|
127
|
+
|
|
128
|
+
**2 · Design Iteration Loop** — one active-learning round, from dossier to next-round proposals.
|
|
129
|
+
|
|
130
|
+

|
|
131
|
+
|
|
132
|
+
**3 · Hypothesis Tournament** — Generate → Reflect → Rank → Evolve, plus the fine-tuning flywheel.
|
|
133
|
+
|
|
134
|
+

|
|
135
|
+
|
|
136
|
+
**4 · Wet-Lab Round Trip** — protocol through the safety boundary, instruments, and back as provenance.
|
|
137
|
+
|
|
138
|
+

|
|
139
|
+
|
|
140
|
+
**5 · Fork / Snapshot Branching** — sandbox lifecycle as experiment tree.
|
|
141
|
+
|
|
142
|
+

|
|
143
|
+
|
|
144
|
+
**6 · Campaign Pipeline** — target ID through trial design with human gates and failure loops.
|
|
145
|
+
|
|
146
|
+

|
|
147
|
+
|
|
148
|
+
Styled HTML versions (dark blueprint pages with legends/captions) live in
|
|
149
|
+
[`diagrams/artifacts/`](diagrams/artifacts/) — open locally in a browser.
|
|
150
|
+
|
|
151
|
+
## Repository Layout
|
|
152
|
+
|
|
153
|
+
| Path | Contents |
|
|
154
|
+
|---|---|
|
|
155
|
+
| [`docs/architecture.md`](docs/architecture.md) | Architectural blocks A–F, components, responsibilities, interfaces |
|
|
156
|
+
| [`docs/flows.md`](docs/flows.md) | End-to-end flows: design iteration loop, fork/branch, review gates, wet-lab round trip |
|
|
157
|
+
| [`docs/blocks/`](docs/blocks/) | One deep-dive doc per block (A–F) |
|
|
158
|
+
| [`docs/research-landscape.md`](docs/research-landscape.md) | Review vs. Google AI co-scientist, Anthropic, Isomorphic, Cradle, Lila, FutureHouse, Coscientist, OpenAI Rosalind |
|
|
159
|
+
| [`contracts/`](contracts/README.md) | The five shared integration contracts (StageTask, ToolInvocation, ProtocolSubmission, AssayResult, ProvenanceRecord) |
|
|
160
|
+
| [`diagrams/`](diagrams/) | SVG diagrams + styled HTML artifact pages |
|
|
161
|
+
|
|
162
|
+
## Architectural Blocks at a Glance
|
|
163
|
+
|
|
164
|
+
| Block | Name | Layer | Can start with |
|
|
165
|
+
|---|---|---|---|
|
|
166
|
+
| [A](docs/blocks/A-orchestration.md) | Workflow & Orchestration | L1 | stub tool endpoints |
|
|
167
|
+
| [B](docs/blocks/B-agents.md) | Agent Workforce | L2 | virtual lab + mocked models |
|
|
168
|
+
| [C](docs/blocks/C-models-knowledge.md) | Model & Knowledge Services | L2 | open-source FMs on a GPU box |
|
|
169
|
+
| [D](docs/blocks/D-lab-execution.md) | Lab Execution | L2/L3 | full virtual lab simulator |
|
|
170
|
+
| [E](docs/blocks/E-simulation-data.md) | Simulation & Data Services | L2 | existing MD/docking tools |
|
|
171
|
+
| [F](docs/blocks/F-infrastructure.md) | Infrastructure (AgentENV) | L3 | exists — integrate |
|
|
172
|
+
|
|
173
|
+
## Design Principles
|
|
174
|
+
|
|
175
|
+
1. **Contract-first integration** — blocks communicate only through five versioned
|
|
176
|
+
schemas; nothing else couples them.
|
|
177
|
+
2. **Hardware behind an abstraction** — agents see the Instrument Abstraction Layer
|
|
178
|
+
(IAL) only; a Virtual Lab Simulator is a drop-in stand-in for real robots.
|
|
179
|
+
3. **State is snapshot-able** — every experiment branch runs in a sandbox that can be
|
|
180
|
+
forked, paused at review gates, and replayed for audits.
|
|
181
|
+
4. **Provenance is immutable** — every artifact carries full lineage (inputs, model
|
|
182
|
+
versions, prompts, instrument run IDs) in WORM storage.
|
|
183
|
+
5. **Safety is non-bypassable** — a policy engine sits in the physical-action path,
|
|
184
|
+
outside any agent's trust boundary.
|
|
185
|
+
|
|
186
|
+
## References & Sources
|
|
187
|
+
|
|
188
|
+
The architecture draws on published work from teams operating in this space. The
|
|
189
|
+
full review — what each system does, how it compares, and which learnings were
|
|
190
|
+
folded into this design — is in [`docs/research-landscape.md`](docs/research-landscape.md).
|
|
191
|
+
|
|
192
|
+
**Key sources:**
|
|
193
|
+
|
|
194
|
+
- Google — [AI co-scientist](https://research.google/blog/accelerating-scientific-breakthroughs-with-an-ai-co-scientist/) ([paper](https://arxiv.org/abs/2502.18864)) · [AlphaFold 3](https://www.nature.com/articles/s41586-024-07487-w) · [Isomorphic Labs Drug Design Engine](https://www.isomorphiclabs.com/articles/the-isomorphic-labs-drug-design-engine-unlocks-a-new-frontier) · [Bioresilience approach](https://www.isomorphiclabs.com/articles/our-approach-to-bioresilience)
|
|
195
|
+
- Anthropic — [Claude for Life Sciences](https://www.anthropic.com/news/claude-for-life-sciences) · [Model Hardware Standard](https://www.anthropic.com/news/model-hardware-standard-research-preview)
|
|
196
|
+
- Cradle Bio — [Platform](https://www.cradle.bio/platform) · [Series B / wet-lab expansion](https://techcrunch.com/2024/11/26/cradle-builds-out-its-protein-design-ai-platform-and-wet-lab-with-73m-in-new-funding/)
|
|
197
|
+
- FutureHouse — [Robin multi-agent system](https://www.futurehouse.org/research-announcements)
|
|
198
|
+
- Lila Sciences — [Agent-driven science on NVIDIA BioNeMo](https://www.lilasciences.com/news/building-the-agent-driven-era-of-science-with-nvidia-bionemo-agent-toolkit)
|
|
199
|
+
- Helical — [Virtual AI lab / Helix-mRNA FM](https://www.helical.bio/)
|
|
200
|
+
- Coscientist (CMU) — [Autonomous chemical research with LLMs + robotics, Nature 2023](https://www.nature.com/articles/s41586-023-06792-0)
|
|
201
|
+
- OpenAI + Retro Biosciences — [GPT-4b micro protein engineering, MIT Tech Review](https://www.technologyreview.com/2024/12/09/1108188/openai-model-for-protein-engineering-gpt-4b-micro-retro-biosciences/)
|
|
202
|
+
- Chai Discovery — [chai-1/chai-2 structure & antibody models](https://www.chaidiscovery.com/)
|